These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28649503)

  • 1. Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator.
    Jazayeri MA; Emert MP; Bartos J; Tabbert T; Lakkireddy DR; Jazayeri MR
    HeartRhythm Case Rep; 2017 Jun; 3(6):306-310. PubMed ID: 28649503
    [No Abstract]   [Full Text] [Related]  

  • 2. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.
    Probst V; Boveda S; Sadoul N; Marquié C; Chauvin M; Mondoly P; Gras D; Jacon P; Defaye P; Leclercq C; Anselme F
    Arch Cardiovasc Dis; 2020 May; 113(5):359-366. PubMed ID: 32334981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions.
    Verma N; Rhyner J; Knight BP
    Expert Rev Cardiovasc Ther; 2015; 13(9):989-99. PubMed ID: 26308601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
    Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: Perspectives from the clinical experience of a U.S. panel of physicians.
    Essandoh MK; Mark GE; Aasbo JD; Joyner CA; Sharma S; Decena BF; Bolin ED; Weiss R; Burke MC; McClernon TR; Daoud EG; Gold MR
    Pacing Clin Electrophysiol; 2018 Jul; 41(7):807-816. PubMed ID: 29754394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
    Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.
    Essandoh MK; Portillo JG; Weiss R; Otey AJ; Zuleta-Alarcon AN; Humeidan ML; Torres JL; Flores AS; Castellon-Larios K; Abdel-Rasoul M; Andritsos MJ; Perez WJ; Stein EJ; Turner KR; Dimitrova GT; Awad H; Bhandary SP; Tripathi RS; Joseph NC; Hummel JD; Augostini RS; Kalbfleisch SJ; Tyler JD; Houmsse M; Daoud EG
    J Clin Anesth; 2016 Jun; 31():53-9. PubMed ID: 27185678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.
    Sanghera R; Sanders R; Husby M; Bentsen JG
    Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to Minimizing Periprocedural Complications During Subcutaneous Implantable Cardioverter-defibrillator Placement.
    Vedachalam S; Cook S; Koppert T; Okabe T; Weiss R; Afzal MR
    J Innov Card Rhythm Manag; 2020 May; 11(5):4100-4105. PubMed ID: 32461815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Subcutaneous Defibrillator Implantation in a Pregnant Patient With Long QT Syndrome.
    Myadam R; Gupta SK
    JACC Case Rep; 2021 Mar; 3(3):504-507. PubMed ID: 34317568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful intermuscular implantation of subcutaneous implantable cardioverter defibrillator in a Japanese patient with pectus excavatum.
    Kondo Y; Ueda M; Winter J; Nakano M; Nakano M; Ishimura M; Miyazawa K; Tateno K; Kobayashi Y
    J Arrhythm; 2017 Feb; 33(1):63-65. PubMed ID: 28217231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive epicardial implantable cardioverter-defibrillator placement for infants and children: An effective alternative to the transvenous approach.
    Schneider AE; Burkhart HM; Ackerman MJ; Dearani JA; Wackel P; Cannon BC
    Heart Rhythm; 2016 Sep; 13(9):1905-12. PubMed ID: 27321244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator.
    Adduci C; Palano F; Francia P
    J Clin Med; 2018 Mar; 7(3):. PubMed ID: 29534478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonthoracotomy implantable cardioverter defibrillator placement in children: use of subcutaneous array leads and abdominally placed implantable cardioverter defibrillators in children.
    Gradaus R; Hammel D; Kotthoff S; Böcker D
    J Cardiovasc Electrophysiol; 2001 Mar; 12(3):356-60. PubMed ID: 11291811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation.
    Kiamanesh O; O'Neill D; Sivakumaran S; Kimber S
    HeartRhythm Case Rep; 2015 Jul; 1(4):257-259. PubMed ID: 28491562
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful implantation of a subcutaneous cardiac defibrillator in a patient with a preexisting deep brain stimulator.
    Bader Y; Weinstock J
    HeartRhythm Case Rep; 2015 Jul; 1(4):241-244. PubMed ID: 28491558
    [No Abstract]   [Full Text] [Related]  

  • 19. Lead Macrodislodgement of a Subcutaneous Implantable Cardioverter-Defibrillator Results in a Reel Problem.
    El-Zein RS; Shah A; Luli J; Stelzer M; Fu E; Amin AK
    JACC Case Rep; 2021 Mar; 3(3):523-527. PubMed ID: 34317572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
    J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.